Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer

Clinical trial NCT06528483 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06528483
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Bladder Urothelial Carcinoma Bladder Neoplasm Muscle-Invasive Bladder Carcinoma

Start date: 2024-12-02
Primary completion: 2026-12-31
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.